Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485800
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1485800
Immunoassay for Neurological Biomarkers Market, By Disease Type, By Product, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 397 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Immunoassay for Neurological Biomarkers Market size was valued at USD 707.67 Million in 2023, expanding at a CAGR of 17.5% from 2024 to 2032.
Immunoassays for neurological biomarkers are laboratory techniques used to measure the levels of certain molecules in biological samples, such as blood or cerebrospinal fluid, that are indicative of neurological conditions or diseases. The rising prevalence of neurological disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis creates a growing need for reliable biomarkers for early diagnosis, prognosis, and monitoring of disease progression. However, the market is facing some regulatory approval for new biomarkers and immunoassays which can be a lengthy and costly process, hindering the translation of research findings into clinically useful diagnostics. Furthermore, there is a growing emphasis on the development of biomarkers for early diagnosis and monitoring of neurological diseases, creating opportunities in future.
Immunoassay for Neurological Biomarkers Market- Market Dynamics
Rising cases of neurological and psychiatric disorders
The Immunoassay for Neurological Biomarkers market plays a significant role in the detection and diagnosis of neurological and psychiatric disorders. Immunoassays allow for the early detection of neurological biomarkers associated with various disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and others. Early detection enables early intervention and treatment, potentially slowing down disease progression and improving patient outcomes. According to the World Health Organization (WHO), more than 3 billion people worldwide are living with a neurological condition due to illness & disability. In addition, over 80% of neurological deaths occur in low- and middle-income countries.
Immunoassay for Neurological Biomarkers Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.5% over the forecast period (2024-2032)
Based on disease type segmentation, Alzheimer's disease was predicted to show maximum market share in the year 2023
Based on technology segmentation, radioimmunoassays (RIA) was the leading type in 2023
Based on end user segmentation, hospitals were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Immunoassay for Neurological Biomarkers Market- Segmentation Analysis:
The Global Immunoassay for Neurological Biomarkers Market is segmented based on Disease Type, Product, End User, Technology, and Region.
The market is divided into six categories based on disease type: Biomarker immunoassays enable early detection of AD even before clinical symptoms appear. Immunoassays are widely used in clinical trials aimed at developing new therapies for AD. They help researchers measure the impact of experimental treatments on biomarker levels and assess their potential efficacy and safety.
The market is divided into six categories based on end user: Immunoassays for neurological biomarkers are widely used in hospitals for various purposes related to the diagnosis, prognosis, and monitoring of neurological disorders. For instance, levels of certain biomarkers might indicate the severity or progression of a disease, helping clinicians predict the likely course of the illness and plan appropriate treatment strategies.
Immunoassay for Neurological Biomarkers Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America has the largest market share in terms of revenue across the world for the immunoassay neurological biomarkers market. This is due to better government initiatives and a strong economy. The United States is a leader in this market, driven by the increasing use of molecular diagnosis. In Europe, the market is growing due to rising competition and increased awareness among the population. The stakeholders' focus on research projects involving proteins, associated biomolecules, and genes are the key factors driving the growth of the neuro immunoassay market in Europe.
Immunoassay for Neurological Biomarkers Market- Competitive Landscape:
The market for immunoassays used for neurological biomarkers is expanding rapidly due to various strategic initiatives taken by market players. These initiatives include the development of advanced biomarker technology for diagnostic and treatment research. For instance, in December 2022, the United States FDA approved two immunoassays developed by F. Hoffmann-La Roche Ltd. These immunoassays are Elecsys Phospho-Tau (181P) CSF (pTau181) and Elecsys beta-Amyloid (1-42) CSF II (Abeta42). These assays are useful for measuring two important biomarkers, tau proteins, and beta-amyloid, in adult patients. They aid in the confirmation of Alzheimer's disease diagnosis.
Recent Developments:
In February 2024, Abbott and Fujirebio announced partnering to develop a research-use-only test for the neurofilament-light chain (NfL). The neurology biomarker assay will be available for use on Abbott's Alinity I instrument and also will be offered to researchers conducting studies demonstrating the utility of the NfL biomarker.
In March 2023, H.U. Group Holdings Inc. and its subsidiary, Fujirebio, announced the release of two new assays, Lumipulse G NfL CSF and Lumipulse G NfL Blood, for LUMIPULSE G immunoassay systems. These CLEIA assays enable the accurate measurement of Neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
QIAGEN
Abbott
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Merck KGaA
F. Hoffmann La-Roche Ltd.
Nimble Therapeutics
ADx NeuroSciences NV
Enrolmmun
ACOBIOM
Banyan Biomarkers Inc.
Olink Biosciences
Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Alzheimer's Disease
- Parkinson's Disease
- Huntington's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Spinal Muscular Atrophy (SMA)
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Instruments
- Reagents
- Services
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Clinics
- Academic Organizations
- Biopharmaceutical Companies
- Pharmaceutical Companies
- Others
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Radioimmunoassays (RIA)
- Polymerase Chain Reaction (PCR)
- ELISA
- Western Blot
- Rapid Tests
- ELISPOT
GLOBAL IMMUNOASSAY FOR NEUROLOGICAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2703
Table of Contents
1.Immunoassay For Neurological Biomarkers Market Overview
- 1.1.Study Scope
- 1.2.Market Estimation Years
2.Executive Summary
- 2.1.Market Snippet
- 2.1.1.Immunoassay For Neurological Biomarkers Market Snippet by Disease Type
- 2.1.2.Immunoassay For Neurological Biomarkers Market Snippet by Product
- 2.1.3.Immunoassay For Neurological Biomarkers Market Snippet by End User
- 2.1.4.Immunoassay For Neurological Biomarkers Market Snippet by Technology
- 2.1.5.Immunoassay For Neurological Biomarkers Market Snippet by Country
- 2.1.6.Immunoassay For Neurological Biomarkers Market Snippet by Region
- 2.2.Competitive Insights
3.Immunoassay For Neurological Biomarkers Key Market Trends
- 3.1.Immunoassay For Neurological Biomarkers Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
- 3.2.Immunoassay For Neurological Biomarkers Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
- 3.3.Immunoassay For Neurological Biomarkers Market Opportunities
- 3.4.Immunoassay For Neurological Biomarkers Market Future Trends
4.Immunoassay For Neurological Biomarkers Industry Study
- 4.1.PEST Analysis
- 4.2.Porter's Five Forces Analysis
- 4.3.Growth Prospect Mapping
- 4.4.Regulatory Framework Analysis
5.Immunoassay For Neurological Biomarkers Market: COVID-19 Impact Analysis
- 5.1.Pre-COVID-19 Impact Analysis
- 5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments
6.Immunoassay For Neurological Biomarkers Market Landscape
- 6.1.Immunoassay For Neurological Biomarkers Market Share Analysis, 2023
- 6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis
7.Immunoassay For Neurological Biomarkers Market - By Disease Type
- 7.1.Overview
- 7.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 7.1.2.Alzheimer's Disease
- 7.1.3.Parkinson's Disease
- 7.1.4.Huntington's Disease
- 7.1.5.Amyotrophic Lateral Sclerosis (ALS)
- 7.1.6.Spinal Muscular Atrophy (SMA)
- 7.1.7.Others
8.Immunoassay For Neurological Biomarkers Market - By Product
- 8.1.Overview
- 8.1.1.Segment Share Analysis, By Product, 2023 & 2032 (%)
- 8.1.2.Instruments
- 8.1.3.Reagents
- 8.1.4.Services
9.Immunoassay For Neurological Biomarkers Market - By End User
- 9.1.Overview
- 9.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2.Hospitals
- 9.1.3.Clinics
- 9.1.4.Academic Organizations
- 9.1.5.Biopharmaceutical Companies
- 9.1.6.Pharmaceutical Companies
- 9.1.7.Others
10.Immunoassay For Neurological Biomarkers Market - By Technology
- 10.1.Overview
- 10.1.1.Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 10.1.2.Radioimmunoassays (RIA)
- 10.1.3.Polymerase Chain Reaction (PCR)
- 10.1.4.ELISA
- 10.1.5.Western Blot
- 10.1.6.Rapid Tests
- 10.1.7.ELISPOT
11.Immunoassay For Neurological Biomarkers Market- By Geography
- 11.1.Introduction
- 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2.North America
- 11.2.1.Overview
- 11.2.2.Immunoassay For Neurological Biomarkers Key Manufacturers in North America
- 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.5.North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.6.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.7.North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.8.U.S.
- 11.2.8.1.Overview
- 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.8.4.U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.8.5.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8.6.U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.9.Canada
- 11.2.9.1.Overview
- 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.9.4.Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.2.9.5.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9.6.Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.Europe
- 11.3.1.Overview
- 11.3.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Europe
- 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.5.Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.6.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.7.Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.8.Germany
- 11.3.8.1.Overview
- 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.8.4.Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.8.5.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8.6.Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.9.Italy
- 11.3.9.1.Overview
- 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.9.4.Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.9.5.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9.6.Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.10.United Kingdom
- 11.3.10.1.Overview
- 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.10.4.United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.10.5.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10.6.United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.11.France
- 11.3.11.1.Overview
- 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.11.4.France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.11.5.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11.6.France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.12.Russia
- 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.12.3.Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.12.4.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12.5.Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.13.Netherlands
- 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.13.3.Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.13.4.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13.5.Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.14.Sweden
- 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.14.3.Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.14.4.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14.5.Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.15.Poland
- 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.15.3.Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.15.4.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15.5.Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.16.Rest of Europe
- 11.3.16.1.Overview
- 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.16.4.Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.3.16.5.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16.6.Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.Asia Pacific (APAC)
- 11.4.1.Overview
- 11.4.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Asia Pacific
- 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.5.Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.6.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.7.Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.8.India
- 11.4.8.1.Overview
- 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.8.4.India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.8.5.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8.6.India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.9.China
- 11.4.9.1.Overview
- 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.9.4.China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.9.5.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9.6.China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.10.Japan
- 11.4.10.1.Overview
- 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.10.4.Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.10.5.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10.6.Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.11.South Korea
- 11.4.11.1.Overview
- 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.11.4.South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.11.5.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11.6.South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.12.Australia
- 11.4.12.1.Overview
- 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.12.4.Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.12.5.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12.6.Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.13.Thailand
- 11.4.13.1.Overview
- 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.13.4.Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.13.5.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13.6.Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.14.Indonesia
- 11.4.14.1.Overview
- 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.14.4.Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.14.5.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14.6.Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.15.Philippines
- 11.4.15.1.Overview
- 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.15.4.Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.15.5.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15.6.Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.16.Rest of APAC
- 11.4.16.1.Overview
- 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.16.4.Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.4.16.5.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16.6.Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.Latin America
- 11.5.1.Overview
- 11.5.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Latin America
- 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.5.Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.6.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.7.Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.8.Brazil
- 11.5.8.1.Overview
- 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.8.4.Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.8.5.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8.6.Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.9.Mexico
- 11.5.9.1.Overview
- 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.9.4.Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.9.5.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9.6.Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.10.Argentina
- 11.5.10.1.Overview
- 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.10.4.Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.10.5.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10.6.Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.11.Colombia
- 11.5.11.1.Overview
- 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.11.4.Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.11.5.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11.6.Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.12.Rest of LATAM
- 11.5.12.1.Overview
- 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.12.4.Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.5.12.5.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12.6.Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.Middle East and Africa
- 11.6.1.Overview
- 11.6.2.Immunoassay For Neurological Biomarkers Key Manufacturers in Middle East and Africa
- 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.5.Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.6.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.7.Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.8.Saudi Arabia
- 11.6.8.1.Overview
- 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.8.4.Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.8.5.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8.6.Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.9.United Arab Emirates
- 11.6.9.1.Overview
- 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.9.4.United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.9.5.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9.6.United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.10.Israel
- 11.6.10.1.Overview
- 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.10.4.Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.10.5.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10.6.Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.11.Turkey
- 11.6.11.1.Overview
- 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.11.4.Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.11.5.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11.6.Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.12.Algeria
- 11.6.12.1.Overview
- 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.12.4.Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.12.5.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12.6.Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.13.Egypt
- 11.6.13.1.Overview
- 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.13.4.Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.13.5.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13.6.Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.14.Rest of MEA
- 11.6.14.1.Overview
- 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.14.4.Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 11.6.14.5.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14.6.Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.Key Vendor Analysis- Immunoassay For Neurological Biomarkers Industry
- 12.1.Competitive Dashboard
- 12.2.Company Profiles
- 12.2.1.QIAGEN
- 12.2.2.Abbott
- 12.2.3.Merck & Co., Inc.
- 12.2.4.Johnson & Johnson Services, Inc.
- 12.2.5.Thermo Fisher Scientific, Inc.
- 12.2.6.Bio-Rad Laboratories, Inc.
- 12.2.7.Sysmex Corporation
- 12.2.8.Merck KGaA
- 12.2.9.F. Hoffmann La-Roche Ltd.
- 12.2.10.Nimble Therapeutics
- 12.2.11.ADx NeuroSciences NV
- 12.2.12.Enrolmmun
- 12.2.13.ACOBIOM
- 12.2.14.Banyan Biomarkers Inc.
- 12.2.15.Olink Biosciences
- 12.2.16.Others
13.360 Degree Analyst View
14.Appendix
- 14.1.Research Methodology
- 14.2.References
- 14.3.Abbreviations
- 14.4.Disclaimer
- 14.5.Contact Us
Product Code: ANV2703
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Immunoassay For Neurological Biomarkers Market: Disease Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Disease Type
- TABLE Global Immunoassay For Neurological Biomarkers Market, by Disease Type 2019-2032 (USD Million)
- TABLE Immunoassay For Neurological Biomarkers Market: Product Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Product
- TABLE Global Immunoassay For Neurological Biomarkers Market, by Product 2019-2032 (USD Million)
- TABLE Immunoassay For Neurological Biomarkers Market: End User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Immunoassay For Neurological Biomarkers Market, by End User 2019-2032 (USD Million)
- TABLE Immunoassay For Neurological Biomarkers Market: Technology Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global Immunoassay For Neurological Biomarkers Market, by Technology 2019-2032 (USD Million)
- TABLE Immunoassay For Neurological Biomarkers Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Immunoassay For Neurological Biomarkers Market, by Region 2019-2032 (USD Million)
- TABLE North America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
- TABLE North America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
- TABLE North America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
- TABLE North America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
- TABLE North America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
- TABLE Europe Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Europe Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
- TABLE Europe Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
- TABLE Europe Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
- TABLE Asia Pacific Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
- TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
- TABLE Latin America Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
- TABLE Latin America Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Product, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by End User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Immunoassay For Neurological Biomarkers Market, by Technology, 2019-2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.